tiprankstipranks
Aeglea Biotherapeutics Inc (AGLE)
NASDAQ:AGLE
US Market

Aeglea Biotherapeutics (AGLE) Ownership - Who Owns Aeglea Biotherapeutics?

344 Followers

Aeglea Biotherapeutics (AGLE) Ownership Overview

0.00%0.00%66.86%33.14%
66.86% Other Institutional Investors
33.14% Public Companies and
Individual Investors
The ownership structure of Aeglea Biotherapeutics (AGLE) stock is a mix of institutional, retail and individual investors. Approximately 66.86% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 33.14% is owned by Public Companies and Individual Investors.
The ownership structure of Aeglea Biotherapeutics (AGLE) stock is a mix of institutional, retail and individual investors. Approximately 66.86% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 33.14% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Currently, No Data Available
Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2023Bought$828651
Sep 30, 2023Bought$993671
Sep 30, 2023Bought$4635657
Sep 30, 2023Bought$9810449

Top Shareholders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

Top Mutual Fund Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Aeglea Biotherapeutics Inc (AGLE)?
According to the latest TipRanks data, approximately 66.86% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 33.14% is held by retail investors.
    What percentage of Aeglea Biotherapeutics Inc (AGLE) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 66.86% of Aeglea Biotherapeutics Inc (AGLE) stock is held by institutional investors.
      What percentage of Aeglea Biotherapeutics Inc (AGLE) stock is held by retail investors?
      According to the latest TipRanks data, approximately 33.14% of Aeglea Biotherapeutics Inc (AGLE) stock is held by retail investors.
        Who owns the most shares of Aeglea Biotherapeutics Inc (AGLE)?
        Currently, no data Available
        What is the significance of the ownership structure for a publicly traded company?
        The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis